Use of Darunavir-Cobicistat as a Treatment Option for Critically Ill Patients with SARS-CoV-2 Infection
Kim et al., Yonsei Medical Journal, doi:10.3349/ymj.2020.61.9.826
https://c19early.org/kim25.html